Allergan and Medicines360 Announce Donation of Intrauterine Devices (IUD) to the Centers for Disease Control (CDC) Foundation to Help Address Microcephaly Impact from Zika Virus in Puerto Rico
Allergan plc, a leading global pharmaceutical company, and Medicines360, a nonprofit women’s health pharmaceutical company with a mission of expanding access to quality medicines, today announced that they will donate 10,000 units of their hormonal IUD, LILETTA®.
Could The Most Effective Birth Control Soon Become The Cheapest?
The most effective reversible forms of birth control are mostly priced out of reach for millions of women who need it most—until now. An unusual partnership between a nonprofit pharmaceutical company and a traditional pharmaceutical distributor aims to increase access to IUDs (intrauterine devices) for U.S. servicewomen and in public clinics.